RBC Capital analyst Douglas Miehm notes Valeant Pharmaceuticals (NYSE: VRX) Derm NRx (largely Walgreens) decreased 6.0% week over week. Meanwhile ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE